TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 71 filers reported holding TREACE MED CONCEPTS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $301,591 | -49.9% | 45,352 | -1.7% | 0.00% | -100.0% |
| Q1 2024 | $602,062 | -2.8% | 46,135 | -5.0% | 0.00% | 0.0% |
| Q4 2023 | $619,395 | -6.6% | 48,580 | -4.0% | 0.00% | 0.0% |
| Q3 2023 | $663,484 | -48.2% | 50,609 | +1.0% | 0.00% | -50.0% |
| Q2 2023 | $1,281,251 | +79.7% | 50,088 | +77.0% | 0.00% | +100.0% |
| Q1 2023 | $712,978 | +11.7% | 28,304 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $638,064 | +5.3% | 27,754 | +1.1% | 0.00% | 0.0% |
| Q3 2022 | $606,000 | +49.6% | 27,443 | -2.8% | 0.00% | 0.0% |
| Q2 2022 | $405,000 | -18.8% | 28,227 | +6.9% | 0.00% | 0.0% |
| Q1 2022 | $499,000 | -10.6% | 26,405 | -11.8% | 0.00% | 0.0% |
| Q4 2021 | $558,000 | +253.2% | 29,934 | +410.4% | 0.00% | – |
| Q3 2021 | $158,000 | -66.5% | 5,865 | -61.1% | 0.00% | -100.0% |
| Q2 2021 | $471,000 | – | 15,061 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kent Lake Capital LLC | 750,000 | $4,987,500 | 2.25% |
| Soleus Capital Management, L.P. | 2,365,648 | $15,731,559 | 1.39% |
| GAGNON SECURITIES LLC | 483,581 | $3,215,814 | 0.72% |
| ARMISTICE CAPITAL, LLC | 5,360,000 | $35,644,000 | 0.45% |
| Divisadero Street Capital Management, LP | 114,400 | $760,760 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 191,427 | $1,273 | 0.09% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 212,976 | $1,416,290 | 0.09% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 526,918 | $3,504,005 | 0.07% |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 3,681,718 | $24,483,425 | 0.06% |
| Lighthouse Investment Partners, LLC | 167,500 | $1,113,875 | 0.04% |